The Biomarkers market size is expected to reach $150.52 billion in 2030 at a CAGR of 14.2%, driven by increasing incidence of cardiovascular diseases.
Read More
The Biologics Manufacturing market size is expected to reach $106.08 billion in 2030 at a CAGR of 20.3%, driven by rising prevalence of chronic diseases.
Read More
The Biologics CDMO market size is expected to reach $48.07 billion in 2030 at a CAGR of 14.9%, driven by surging demand for cell and gene therapies.
Read More
The Biologics market size is expected to reach $827.24 billion in 2030 at a CAGR of 11.2%, driven by rising demand for personalized medicine.
Read More
Biological Stains Market Expected To Reach $12.62 Billion By 2030 As Growth Accelerates At 6.6% CAGR
The Biological Stains market size is expected to reach $12.63 billion in 2030 at a CAGR of 6.6%, driven by growth of pharmaceutical and biotechnology industries.
Read More
The Biologic & Biosimilar RA Drugs market size is expected to reach $20.53 billion in 2030 at a CAGR of 7.2%, driven by rising global healthcare spending.
Read More
The Bioengineered Protein Drugs market size is expected to reach $646.93 billion in 2030 at a CAGR of 8.4%, driven by increasing prevalence of chronic diseases.
Read More
The Biodegradable Medical Polymers market size is expected to reach $5.95 billion in 2030 at a CAGR of 16.4%, driven by rising demand for minimally invasive procedures.
Read More
The Bioconvergence market size is expected to reach $263.67 billion in 2030 at a CAGR of 10.8%, driven by growing emphasis on personalized medicine solutions.
Read More
The Biobetters market size is expected to reach $121.61 billion in 2030 at a CAGR of 9.7%, driven by increasing prevalence of chronic and autoimmune diseases.
Read More